Type 2 Diabetes in the U.S.: Causes, Costs & Prevention
This paper examines Type 2 Diabetes (T2D) as a growing public health crisis in the United States and developing countries. It discusses the biological mechanisms of insulin resistance, genetic and lifestyle risk factors, and the demographic groups most vulnerable to the disease. The paper presents U.S. prevalence statistics alongside state-level data, then analyzes the substantial direct and indirect economic costs of diagnosed diabetes. It also reviews psychosocial and family-based treatment approaches, outlines practical steps for managing and reducing T2D incidence, and concludes with policy recommendations emphasizing lifestyle change, community health strategies, and global public health priorities.
- Introduction to Type 2 Diabetes: Biological mechanisms of insulin resistance and T2D
- Prevalence and Demographics: Risk groups, genetic factors, and global spread
- T2D Statistics in the U.S. and State-Level Rates: National and state-level diabetes prevalence data
- The Economic Cost of Treating T2D: Direct and indirect financial costs of diabetes care
- Psychosocial Management and Family-Based Interventions: Family and group strategies for diabetes control
- Steps to Address T2D and Policy Recommendations: Lifestyle, community, and policy prevention strategies
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Moves logically from biological mechanisms to epidemiology, economics, and policy, giving readers a complete picture of the T2D burden.
- Grounds claims in concrete statistics—such as the 41% rise in diabetes costs from $174 billion to $245 billion—making abstract health trends tangible.
- Balances clinical detail with practical recommendations, bridging the gap between research findings and actionable public health guidance.
Key academic technique demonstrated
The paper effectively uses a multi-dimensional framing strategy: it situates Type 2 Diabetes simultaneously as a biological, social, economic, and policy problem. By layering these perspectives, the author demonstrates how a single health condition requires interdisciplinary analysis rather than a purely clinical approach. This technique—common in public health writing—strengthens argument depth without requiring experimental data.
Structure breakdown
The paper opens with a definition and biological overview of T2D, then expands outward to global and U.S. epidemiology. A dedicated statistics section narrows focus to state-level data. The economic section quantifies direct and indirect costs using enumerated subcategories for clarity. Two final sections shift to solutions: first addressing psychosocial and family-based interventions, then broader lifestyle and policy steps. A concise recommendation paragraph closes the paper with a call to action.
Introduction to Type 2 Diabetes
Type 2 Diabetes (T2D) was previously known as non-insulin-dependent diabetes. Unlike an individual with Type 1 diabetes, a person with T2D continues to produce insulin, but the body fails to respond to it in a normal manner. Glucose cannot penetrate the cells and supply the required energy—a condition commonly referred to as insulin resistance. Eventually, blood sugar levels rise and cause the pancreas to produce additional insulin. Over time, the pancreas wears out from overworking to generate surplus insulin and becomes unable to produce adequate amounts to keep blood sugar levels normal. Individuals with insulin resistance may or may not develop T2D (Atta-ur-Rahman, Reitz & Choudhary, 2010). This outcome is independent of the pancreas's ability to generate enough insulin to keep blood sugar within normal ranges. In most cases, elevated blood sugar levels are directly related to diabetes.
Children and teens with T2D often rely on exercise, diet, and medications to enhance their bodies' response to insulin and control blood sugar levels. Some may need to take insulin shots or use an insulin pump.
Although the precise cause of T2D is not fully understood, there appears to be an inherited genetic component. Approximately sixty percent of affected children in the U.S. have at least one diabetic parent and may have a significant family history of the illness (Ginsburg & Willard, 2013). In some cases, a parent is diagnosed with T2D at the same time as their child. Most individuals who develop this disease are obese. Excess fat makes it difficult for cells to respond to insulin, and physical inactivity further decreases the body's ability to utilize insulin effectively.
Create your account
Always verify citation format against your institution’s current style guide requirements.